Your browser doesn't support javascript.
loading
Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.
Ouk, Michael; Wu, Che-Yuan; Rabin, Jennifer S; Edwards, Jodi D; Ramirez, Joel; Masellis, Mario; Swartz, Richard H; Herrmann, Nathan; Lanctôt, Krista L; Black, Sandra E; Swardfager, Walter.
Afiliação
  • Ouk M; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Wu CY; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Rabin JS; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada; Harquail Centre for Neuromodulation, Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canad
  • Edwards JD; University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; ICES, Ottawa, Ontario, Canada.
  • Ramirez J; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada; Canadian Partnership for Stroke Recovery, Toronto, Ontario, Canada.
  • Masellis M; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Swartz RH; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; Canadian Partnership for Stroke Recovery, Toronto, Ontario, Canada.
  • Herrmann N; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Lanctôt KL; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; KITE -
  • Black SE; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; Canadian Partnership for Stroke Recovery, Toronto, Ontario, Canada; KITE - Toronto Rehabili
  • Swardfager W; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada; Canadian Partnership for Stroke Recovery, Toronto, Ontario, Canada; KITE - Toronto Rehabilitation Institute, Universi
Neurobiol Aging ; 100: 22-31, 2021 04.
Article em En | MEDLINE | ID: mdl-33461049

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Encéfalo / Inibidores da Enzima Conversora de Angiotensina / Peptídeos beta-Amiloides / Antagonistas de Receptores de Angiotensina / Doença de Alzheimer / Hipertensão Tipo de estudo: Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Neurobiol Aging Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Encéfalo / Inibidores da Enzima Conversora de Angiotensina / Peptídeos beta-Amiloides / Antagonistas de Receptores de Angiotensina / Doença de Alzheimer / Hipertensão Tipo de estudo: Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Neurobiol Aging Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá